EP Patent

EP0375350A2 — Cross-linked vinylpyridinium polymers

Assigned to Smith Kline and French Laboratories Ltd · Expires 1990-06-27 · 36y expired

What this patent protects

Cross-linked polymers of structure (I) in which, R is C 1-20 alkyl, hydroxyC 1-20 alkyl or C 1 -4 alkoxyC 1 -20 alkyl, processes for their preparation, pharmaceutical compositions containing them and their use in therapy as bile acid sequestering agents.

USPTO Abstract

Cross-linked polymers of structure (I) in which, R is C 1-20 alkyl, hydroxyC 1-20 alkyl or C 1 -4 alkoxyC 1 -20 alkyl, processes for their preparation, pharmaceutical compositions containing them and their use in therapy as bile acid sequestering agents.

Drugs covered by this patent

Patent Metadata

Patent number
EP0375350A2
Jurisdiction
EP
Classification
—
Expires
1990-06-27
Drug substance claim
No
Drug product claim
No
Assignee
Smith Kline and French Laboratories Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.